相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A mouse model for HBV immunotolerance and immunotherapy
Dan Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2014)
Hepatic Immune Regulation and Its Involvement in Viral Hepatitis Infection
Percy A. Knolle et al.
GASTROENTEROLOGY (2014)
Cyclic guanosine monophosphate/adenosine monophosphate synthase (cGAS), innate immune responses, and viral hepatitis
Eloi R. Verrier et al.
HEPATOLOGY (2014)
Cytidine Deamination and cccDNA Degradation: A New Approach for Curing HBV?
Siyuan Ding et al.
HEPATOLOGY (2014)
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
John W. Schoggins et al.
NATURE (2014)
Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
Xuesen Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
Moses T. Bility et al.
PLOS PATHOGENS (2014)
Anticancer Flavonoids Are Mouse-Selective STING Agonists
Sujeong Kim et al.
ACS CHEMICAL BIOLOGY (2013)
Chronic hepatitis B: What should be the goal for new therapies?
Timothy M. Block et al.
ANTIVIRAL RESEARCH (2013)
Species-specific detection of the antiviral small-molecule compound CMA by STING
Taner Cavlar et al.
EMBO JOURNAL (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B
Jean Publicover et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids
Matthew R. Campagna et al.
JOURNAL OF VIROLOGY (2013)
STING and the innate immune response to nucleic acids in the cytosol
Dara L. Burdette et al.
NATURE IMMUNOLOGY (2013)
Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
Xiao-Dong Li et al.
SCIENCE (2013)
Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses
Daxing Gao et al.
SCIENCE (2013)
Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
Fei Liu et al.
PLOS PATHOGENS (2013)
CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion
Masanori Isogawa et al.
PLOS PATHOGENS (2013)
The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2012)
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management
Mauro Vigano et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients
Birgit Edlich et al.
HEPATOLOGY (2012)
Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity
Sebastian Zeissig et al.
NATURE MEDICINE (2012)
IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B
Jean Publicover et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus
Chunxiao Xu et al.
JOURNAL OF VIROLOGY (2010)
Hepatitis B Virus Suppresses Toll-like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells
Jun Wu et al.
HEPATOLOGY (2009)
Benefits and Risks of Nucleoside Analog Therapy for Hepatitis B
Jules L. Dienstag
HEPATOLOGY (2009)
Benefits and Risks of Interferon Therapy for Hepatitis B
Robert Perrillo
HEPATOLOGY (2009)
Hepatitis B: The Virus and Disease
T. Jake Liang
HEPATOLOGY (2009)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
Jun Wu et al.
HEPATOLOGY (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease
K Kimura et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection
Y Horsmans et al.
HEPATOLOGY (2005)
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo
M Isogawa et al.
JOURNAL OF VIROLOGY (2005)
Hepatocyte turnover during resolution of a transient hepadnaviral infection
J Summers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice
K Kimura et al.
JOURNAL OF IMMUNOLOGY (2002)
Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection
PL Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Targeting Kupffer cells with antisense oligonucleotides
BC Ponnappa et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection
JL Baron et al.
IMMUNITY (2002)
Replication of the human hepatitis delta virus genome is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences
JH Chang et al.
JOURNAL OF VIROLOGY (2001)
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections
JT Guo et al.
JOURNAL OF VIROLOGY (2000)
Hepatitis B virus biology
C Seeger et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
分享论文
